Risk prediction scores for dementia can help clinicians to identify at-risk individuals. If appropriately validated, these scores can also help quantify prevention potential and direct individuals to the most appropriate interventions. A new study validated the CAIDE dementia risk score by associating it with biomarker change over time.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services—part 4 of 6
Alzheimer's Research & Therapy Open Access 11 October 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
World Health Organization. Risk reduction of cognitive decline and dementia: WHO guidelines. (WHO, 2019).
O’Brien, J. T. et al. Association between midlife dementia risk factors and longitudinal brain atrophy: the PREVENT-dementia study. J. Neurol. Neurosurg. Psychiatry 91, 158–161 (2020).
Hou, X. et al. Models for predicting risk of dementia: a systematic review. J. Neurol. Neurosurg. Psychiatry 90, 373–379 (2019).
Cherbuin, N., Shaw, M. E., Walsh, E., Sachdev, P. & Anstey, K. J. Validated Alzheimer’s disease risk index (ANU-ADRI) is associated with smaller volumes in the default mode network in the early 60s. Brain Imaging Behav. 13, 65–74 (2019).
Enache, D. et al. CAIDE Dementia Risk Score and biomarkers of neurodegeneration in memory clinic patients without dementia. Neurobiol. Aging 42, 124–131 (2016).
Ngandu, T. et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): A randomised controlled trial. Lancet 385, 2255–2263 (2015).
Solomon, A., Ngandu, T. & Kivipelto, M. in New Developments in Dementia Prevention Research: State of the Art and Future Possibilities (eds Irving, K. E. et al.) 13–26 (Routledge, 2019).
Stephen, R. et al. Brain volumes and cortical thickness on MRI in the Finnish geriatric intervention study to prevent cognitive impairment and disability (FINGER). Alzheimers Res. Ther. 11, 53 (2019).
Rosenberg, A. et al. Multidomain lifestyle intervention benefits a large elderly population at risk for cognitive decline and dementia regardless of baseline characteristics: the FINGER trial. Alzheimers Dement. 14, 263–270 (2018).
Kivipelto, M., Mangialasche, F. & Ngandu, T. World Wide Fingers Network. Worldwide fingers will advance dementia prevention. Lancet Neurol. 17, 27 (2018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
H.S. has received research funding from the European Union and the Academy of Finland and consultation fees from AC Immune and Merck. R.S. declares no competing interests.
Rights and permissions
About this article
Cite this article
Stephen, R., Soininen, H. Biomarker validation of a dementia risk prediction score. Nat Rev Neurol 16, 135–136 (2020). https://doi.org/10.1038/s41582-020-0316-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41582-020-0316-8
